Sort   by:  
 Page size 
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
UnknownA biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Not available
S-EPMC11001594 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownAntibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425 | biostudies-literature
UnknownImpact of weight loss on ankle-brachial index and interartery blood pressures.
Not available
S-EPMC3968218 | biostudies-literature
UnknownThe long-term effectiveness of a lifestyle intervention in severely obese individuals.
Not available
S-EPMC3574274 | biostudies-literature
UnknownLifestyle change and mobility in obese adults with type 2 diabetes.
Not available
S-EPMC3339039 | biostudies-literature
UnknownFour-year weight losses in the Look AHEAD study: factors associated with long-term success.
Not available
S-EPMC3183129 | biostudies-literature
UnknownMidcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study.
Not available
S-EPMC3790961 | biostudies-literature
UnknownLong-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
Not available
S-EPMC3084497 | biostudies-literature
Sort   by:  
 Page size